AtriCure Announces Tentative Settlement with the Department of Justice


November 6, 2009

November 6, 2009 ¬– AtriCure Inc. said this week it reached a tentative agreement, subject to completion and approval of a written settlement agreement, with the Department of Justice (DOJ) to resolve the issues raised in the DOJ’s investigation and the related qui tam complaint regarding the marketing of the company’s surgical ablation devices.

The whistleblower suit was filed against the company alleging False Claims Act violations related to the marketing of its medical devices.

The agreement includes AtriCure’s assertion that the company and its employees have not engaged in any wrongdoing or illegal activity. Pursuant to the tentative agreement, AtriCure would pay $3.8 million plus interest over a five-year period. Further, as is typical of settlements of this nature, AtriCure has agreed, subject to completion and approval of a written agreement, to enter into a corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services.

For more information: